JRMS-22

N/A

Report date: 2025/03/04 10:33:51
NME

Base Information

Drug NameJRMS-22
Drug Alias NameJRMS-22
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTAR DNA binding protein 43 inhibitors
TargetsTAR DNA binding protein 43
Therapy Area/IndicationsAmyotrophic Lateral SclerosisFrontotemporal DementiaAlzheimer Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuropeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuropeutics IncLifearc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisFrontotemporal DementiaAlzheimer Disease +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A